BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 15 filers reported holding BIOMX INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,401 | -22.2% | 512,502 | -20.5% | 0.05% | -31.6% |
| Q2 2023 | $232,002 | +25.1% | 644,449 | +6.0% | 0.08% | +111.1% |
| Q1 2023 | $185,489 | +45.2% | 608,162 | -11.1% | 0.04% | +176.9% |
| Q4 2022 | $127,787 | -45.2% | 684,451 | 0.0% | 0.01% | -27.8% |
| Q3 2022 | $233,000 | -53.4% | 684,451 | 0.0% | 0.02% | -55.0% |
| Q2 2022 | $500,000 | -62.1% | 684,451 | 0.0% | 0.04% | -48.1% |
| Q1 2022 | $1,321,000 | +20.6% | 684,451 | 0.0% | 0.08% | +13.2% |
| Q4 2021 | $1,095,000 | -47.7% | 684,451 | 0.0% | 0.07% | -53.7% |
| Q3 2021 | $2,094,000 | -44.0% | 684,451 | 0.0% | 0.15% | -17.4% |
| Q2 2021 | $3,737,000 | -23.3% | 684,451 | 0.0% | 0.18% | -62.7% |
| Q1 2021 | $4,874,000 | +11.6% | 684,451 | 0.0% | 0.48% | -43.8% |
| Q4 2020 | $4,367,000 | +0.6% | 684,451 | 0.0% | 0.85% | -23.6% |
| Q3 2020 | $4,339,000 | +14.8% | 684,451 | 0.0% | 1.11% | -19.4% |
| Q2 2020 | $3,778,000 | -26.9% | 684,451 | -7.4% | 1.38% | -74.9% |
| Q1 2020 | $5,171,000 | – | 738,770 | – | 5.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 2,133,402 | $11,648,000 | 1.19% |
| MMCAP International Inc. SPC | 684,451 | $3,737,000 | 0.18% |
| Orbimed Advisors | 2,313,489 | $12,632,000 | 0.13% |
| Taylor Wealth Management Partners | 31,804 | $174,000 | 0.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,207 | $78,000 | 0.04% |
| ROYCE & ASSOCIATES LP | 359,000 | $1,960,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 104,000 | $568,000 | 0.01% |
| J. Goldman & Co LP | 150,000 | $92,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 427,702 | $2,335,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,060 | $6,000 | 0.00% |